Sublingual formulation of riluzole

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11660267
APP PUB NO 20180153794A1
SERIAL NO

15100160

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is sublingual administration of riluzole. In particular, a method for treating a neuropsychiatric disorder or symptom by administering a sublingual formulation of riluzole is provided. In addition, a method of relieving or reducing oral pain using the sublingual formulation of riluzole is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOHAVEN THERAPEUTICS LTD215 CHURCH STREET NEW HAVEN CT 06510

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berman, Robert Stonington, US 25 449
Coric, Vladimir Madison, US 44 62
Saleh, Amgad Dayton, US 3 4
Vladyka, Ronald S Somerset, US 10 47
Yu, Danny Somerville, US 17 267

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 30, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 30, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00